May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Probiotic Eye–Drops Treatment in Patients Affected by Vernal Keratoconjunctivitis
Author Affiliations & Notes
  • A. Iovieno
    Ophthalmology, University Campus Bio–Medico, Rome, Italy
  • M. Sacchetti
    Ophthalmology, University Campus Bio–Medico, Rome, Italy
  • R. Sgrulletta
    Ophthalmology, University Campus Bio–Medico, Rome, Italy
    IRCCS GB Bietti Eye Foundation, Rome, Italy
  • A. Lambiase
    Ophthalmology, University Campus Bio–Medico, Rome, Italy
    IRCCS GB Bietti Eye Foundation, Rome, Italy
  • M. Cortes
    Ophthalmology, University Campus Bio–Medico, Rome, Italy
    IRCCS GB Bietti Eye Foundation, Rome, Italy
  • S. Bonini
    IRCCS San Raffaele La Pisana, Rome, Italy
  • S. Bonini
    Ophthalmology, University Campus Bio–Medico, Rome, Italy
    IRCCS GB Bietti Eye Foundation, Rome, Italy
  • Footnotes
    Commercial Relationships  A. Iovieno, None; M. Sacchetti, None; R. Sgrulletta, None; A. Lambiase, None; M. Cortes, None; S. Bonini, None; S. Bonini, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4998. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Iovieno, M. Sacchetti, R. Sgrulletta, A. Lambiase, M. Cortes, S. Bonini, S. Bonini; Probiotic Eye–Drops Treatment in Patients Affected by Vernal Keratoconjunctivitis . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4998. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Probiotics have been shown to potentially affect allergic inflammation by modulating Th1/Th2 balance. The aim of this study is to evaluate the efficacy of probiotic eye–drops treatment in controlling signs and symptoms of vernal keratoconjunctivitis (VKC).

Methods: : Six patients (age:7–17, mean age 10.8; sex: 4 M, 2 F) affected by moderate to severe VKC in active phase have been included in the study. Solution of freeze–dried inactivated Lactobacillus Acidophilus in saline solution (concentration: 2 x 108/ml) has been administrated as eye–drops 4 times daily for 4 weeks in both eyes. Clinical signs (conjunctival hyperemia, chemosis and secretion, upper tarsal papillae, limbal lesions, superficial punctuate keratitis) and symptoms (itching, photophobia, burning, tearing) were evaluated and scored form 0 to 3 at baseline, after 2 weeks and after 4 weeks of treatment with probiotic eye–drops (follow–up: 2–7 weeks). Topical steroids were allowed as rescue medication. The total signs (TSS) and the total symptoms (TSyS) scores were calculated. Mann–Whitney U–test was used to compare signs and symptoms at different time–points.

Results: : After two weeks of treatment 4 out of 6 patients showed improvement of symptoms (TSyS baseline 5.5±1.5 vs. 3.6±2.4, p=0.028) with significant improvement of photophobia (baseline 2±0.6 vs. 1±0.9; p=0.050). Clinical signs showed improvement from baseline in 5 out of 6 patients after two weeks of treatment that did not reach statistically significant values (TSS: baseline 7 ± 2.8 vs. 2 weeks 5.4 ± 3.2; nss). After two weeks of treatment 1 patients dropped–out because of severe ocular surface inflammation that required topical steroid treatment. At the end of the study patients showed improvement of symptoms (TSyS baseline 5.5±1.5 vs. 4±2.6, nss) and signs with total signs score significantly decreased with respect to baseline (TSS: baseline 7 ± 2.8 vs. 4±2.8; p=0.043). Conjunctival secretion was the only clinical sign improved both at 2 and 4 weeks of treatment with respect to baseline (baseline 1.8±0.3 vs. 1.2±0.8; p=0.030).

Conclusions: : Our data suggest that probiotic eye–drops treatment improves symptoms and signs in patients affected by vernal keratoconjunctivitis. Further extended studies are necessary to establish the possible use of Lactobacillus Acidophilus eye–drops as a therapy for vernal keratoconjunctivitis.

Keywords: conjunctivitis • immunomodulation/immunoregulation • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×